CN102210825B - External applied medicine for treating beriberi and preparation method thereof - Google Patents

External applied medicine for treating beriberi and preparation method thereof Download PDF

Info

Publication number
CN102210825B
CN102210825B CN201110141184XA CN201110141184A CN102210825B CN 102210825 B CN102210825 B CN 102210825B CN 201110141184X A CN201110141184X A CN 201110141184XA CN 201110141184 A CN201110141184 A CN 201110141184A CN 102210825 B CN102210825 B CN 102210825B
Authority
CN
China
Prior art keywords
external applied
medicine
percent
applied medicine
borax
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110141184XA
Other languages
Chinese (zh)
Other versions
CN102210825A (en
Inventor
王友付
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wang Youfu
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201110141184XA priority Critical patent/CN102210825B/en
Publication of CN102210825A publication Critical patent/CN102210825A/en
Application granted granted Critical
Publication of CN102210825B publication Critical patent/CN102210825B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to an external applied medicine for treating beriberi. The external applied medicine consist of the following Chinese herbal medicines in percentage by weight: 15 to 35 percent of glabrous greenbrier rhizome, 15 to 35 percent of yellowmouth dutchmanspipe root, 10 to 25 percent of trifoliate jewelvine root, 10 to 20 percent of Chinese gall and 7 to 15 percent of borax. The external applied medicine is developed through improvement on a descendant nostrum preparation and many years of clinical trials. The external applied medicine is an external applied ointment for treating beriberi and a pure Chinese medicinal preparation, and has the radical treatment effect on multiple kinds of beriberi. After seven days of use, beriberi can be cured and prevented from relapsing within three months. The external applied medicine has the good effect of pain relief, stop of pus and blood, sterilization, antitoinflammatory, antivirus, removal of putrefaction and promotion of tissue regeneration, and enhancement of immunocyte function; moreover, and the external applied medicine is easy to prepare and low in cost, has the excellent effect, and is applicable for industrial processing and production.

Description

Beriberic medicine for external use of a kind of treatment and preparation method thereof
Technical field
The present invention relates to the field of Chinese medicines, particularly relate to a kind of formulated with Chinese medicine extract, the beriberic medicine for external use of special for treating.
Background technology
As everyone knows, vitamin B1 deficiency is a kind of stubborn disease of a kind of people's of having a strong impact on orthobiosis and work, and the people of each types of populations can dye this disease, and this type disease transmission property is strong, is difficult to cure.Only there is 10% population to suffer from vitamin B1 deficiency in various degree among the rural people according to investigations; Especially regional even more serious on the south the Changjiang river, particularly poverty-stricken area and pool, they suffer from vitamin B1 deficiency and do not go treatment; Some indigenous methods of the usefulness that has go simply to handle, but can not fundamentally cure.
Summary of the invention
The present invention is directed to the defective in the above-mentioned field, provide a kind of treatment beriberic medicine for external use, all kinds of vitamin B1 deficiencys are all had the effect of radical cure, to help those people that receive the vitamin B1 deficiency puzzlement, the misery that throws off one's illness.
The beriberic medicine for external use of a kind of treatment, its active ingredient is made up of the crude drug of following percentage composition: Rhizoma Smilacis Glabrae 15-35%, Radix Stephaniae Tetrandrae 15-35%, Radix seu Caulis Derridis Trifoliatae 10-25%, Galla Chinensis 10-20%, Borax 7-15%.
Preferably: Rhizoma Smilacis Glabrae 20-30%, Radix Stephaniae Tetrandrae 20-30%, derris dust 15-25%, Galla Chinensis 15-20%, Borax 10-12%.
More preferably: Rhizoma Smilacis Glabrae 30%, Radix Stephaniae Tetrandrae 20%, derris dust 20%, Galla Chinensis 18%, Borax 12%.
Said medicine for external use is a unguentum.
Said unguentum forms with the solvent composition modulation, and said solvent composition is that the HUOXIANG ZHENGQI SHUI medicament is or/and ethanol.The method for preparing of above-mentioned medicine for external use, each component of percentage composition weighting raw materials is ground into smalls by weight, and mixing adds solvent composition, stirs the furnishing paste and gets final product.
The present invention is mixed with the beriberic active ingredient of treatment with Rhizoma Smilacis Glabrae, Radix Stephaniae Tetrandrae, Radix seu Caulis Derridis Trifoliatae, Galla Chinensis, Borax by certain percentage composition, can be by the medicine for external use excipient.
1. Rhizoma Smilacis Glabrae: be the root of liliaceous plant.
Nature and flavor: sweet, light, flat.
Composition: contain chemical compounds such as Saponin, Mao Rouzhi, resin.
Effect: detoxify, dehumidify, control beriberi, tinea, scabies, carbuncle, swollen etc.
2. Radix Stephaniae Tetrandrae: be the root of Radix Stephaniae Tetrandrae kind of plant Radix Stephaniae Tetrandrae.
Nature and flavor: bitter, cold.
Composition: contain alkaloid, flavonoid glycoside, phenols, organic acid, volatilization wet goods.
Effect: rush down damp and hot, control beriberi, tinea, scabies, skin ulcer etc.
3. derris dust: the powder of producing for the root or the herb of bean tannin plant.
Nature and flavor: bitter, hot, temperature, poisonous.
Composition: contain rotenone, deguelin.
Effect: control beriberi, tinea, scabies, dissipating blood stasis, pain relieving etc.
4. Galla Chinensis: be a times dentistry insecticide angle letter aphid parasite, the worm baby on the Fructus rhois chinensis tree.
Nature and flavor: acid, cold.
Composition: contain chemical compounds such as the gentle acid of grass, resin.
Effect: hold back the open sore part, hemostasis, pain relieving, antibacterial etc.
5. Borax: the crystallization that forms through system for the mineral Borax.
Nature and flavor: sweet, salty, cool.
Composition: contain sodium tetraborate.
Effect: heat clearing away, detoxifcation, removing the necrotic tissue, antibacterial.
This prescription is a pure Chinese medicinal preparation, and the Rhizoma Smilacis Glabrae in the prescription, Radix Stephaniae Tetrandrae, Radix seu Caulis Derridis Trifoliatae are main component, is antibacterial, antiviral, the removing cause of disease of curing the disease.Gallic mainly acting as impelled the ulceration epidermis convergence open sore part, makes the antibacterial at ulceration place lose the condition of existence, promotes cambium to generate, and is accessory drugs.Borax mainly act as detoxifcation, and the pyretic toxicity in affected part is removed the rotten and let fresh grow clearly, help above-mentioned raw materials medicine, and the antibacterial of the strong effect of performance, detoxifcation, the removing cause of disease, conversion pathogenesis, generation joint effect are adjuvant drug.
The present invention adopts unguentum, and its solvent can adopt HUOXIANG ZHENGQI SHUI or/and ethanol, and HUOXIANG ZHENGQI SHUI can produce very strong antibacterial, antiinflammatory, antiviral, pain relieving, antipruritic, the effect of removing the rotten and letting fresh grow, and the treatment vitamin B1 deficiency is had splendid adjuvant treatment effect.The HUOXIANG ZHENGQI SHUI medicament is that the product of commercially available each manufacturer production all can.Ethanol also has antibacterial, and the effect of antiinflammatory can be adopted the Chinese liquor of 25-60 degree.Solvent is avoided the whole water preparations of employing.As long as the amount of solvent can make powder stir into paste and be easy to smear.
The present invention treats the method for preparing of beriberic medicine for external use:
1, according to the rules ratio is put into Rhizoma Smilacis Glabrae powder, Radix Stephaniae Tetrandrae powder, gallnut extract, Borax powder, derris dust through the disinfectant vessel and is stirred respectively.
2, the medicated powder after will stirring is with HUOXIANG ZHENGQI SHUI furnishing unguentum.
3, with the unguentum furnishing pasty state coating again of packing in the disinfectant vial.
Can use the measured Chinese liquor furnishing of matter pasty state coating again when 4, using.
The method for using of treatment vitamin B1 deficiency ointment
1, this ointment can directly be smeared the affected part.
2, must the affected part be cleared up, clean before the coating, coating again after the sterilization.
3, to state of an illness the lighter, epidermis is not coated with 3-4 time the every day of ulceration.
4, to the person of being in a bad way, epidermis ulceration, the blood of suppurating, there is the patient of slough or toe swelling to be no less than every day 5 times, guarantee recovery from illness 5-7 day.
This prescription is made simple, and cost is low, and drug effect is unique, and all kinds of vitamin B1 deficiencys are all had the effect of radical cure, is best suited for the patient of those poor colonies.Effectively do not recur, and have very significant pain relieving, antipruritic, the effect of ending pus and blood, removing the rotten and letting fresh grow.No matter be that the economic condition quality can both processing and fabricating, make things convenient for the patient.
The specific embodiment
Following raw material medicaments and solvent composition are the commercially available prod.The unit of weight of following raw materials according is gram.
Embodiment 1
Rhizoma Smilacis Glabrae 150, Radix Stephaniae Tetrandrae 350, Radix seu Caulis Derridis Trifoliatae 250, Galla Chinensis 100, Borax 150.
Above-mentioned raw materials medicated powder is broken into smalls, stirs, and HUOXIANG ZHENGQI SHUI 2000ml adds the powder internal modulation and becomes paste.
Embodiment 2
Rhizoma Smilacis Glabrae 350, Radix Stephaniae Tetrandrae 300, Radix seu Caulis Derridis Trifoliatae 100, Galla Chinensis 180, Borax 70.
Above-mentioned raw materials medicated powder is broken into smalls, stirs, and the Chinese liquor 2000ml of 45 degree adds the powder internal modulation and becomes paste.
Embodiment 3
Rhizoma Smilacis Glabrae 300, Radix Stephaniae Tetrandrae 200, derris dust 200, Galla Chinensis 180, Borax 120.
Above-mentioned raw materials medicated powder is broken into smalls, stirs, and the Chinese liquor 1000ml of HUOXIANG ZHENGQI SHUI 1000ml and 45 degree adds the powder internal modulation and becomes paste.
Embodiment 4
Rhizoma Smilacis Glabrae 280, Radix Stephaniae Tetrandrae 150, derris dust 220, Galla Chinensis 200, Borax 150.
Above-mentioned raw materials medicated powder is broken into smalls, stirs, and the Chinese liquor 800ml of HUOXIANG ZHENGQI SHUI 1000ml and 56 degree adds the powder internal modulation and becomes paste.
Experimental example: vitamin B1 deficiency treatment clinical experiment data
This medicine warp is many person-times clinical practice for many years, and existing the effect treated 50 examples vitamin B1 deficiency patient in various degree.No matter the age is big or small, sex difference, all radical cure recoveries from illness.The relevant data that writes down for clinical treatment below.
1,20 lighter patients of vitamin B1 deficiency is treated record.Patient age 20-45 year, rural migrant worker 15 people, workman 5 people are engaged in respectively and raise pigs, plant, build worker, compound fertilizer work position; Environmental pollution is heavier, and sanitary condition is poor, and the state of an illness is that toe is itched bitterly; Epidermis is broken, gives 3-4 coating (embodiment 1 preparation) every day, washes the affected part with clear water before the coating; Coating must not have 8 people in 3 days, can fully recover half an hour on foot, has 9 people in 4 days, to fully recover, through the unmanned recurrence of tracing observation and to clothes vitamin B1, vitamin C.
2, record is treated in 30 patients' tracking.Age 17-50 year, professional 20 people are the peasant, and 10 people are the builder, and mostly contact with water, feces, pig, chicken, duck give birth to contaminated environment such as poultry, wear water shoes, rubber overshoes etc. in for a long time.The state of an illness is that the toe seam festers, flows yellow slurry, pus and blood water and rotten interior phenomenon are arranged.To the affected part disinfection, give coating, be no less than 5 coatings (embodiment 3 preparations) every day.Must not walk half an hour behind the coating, preferably rested 3-4 days, and best results, wherein the state of an illness transforms on 20 people, four top margins of a page, begins long cambium, and other 10 people are all recoveries from illness in 5-7 days, give clothes vitamin B1, vitamin C, do not have recurrence in March.
This medical instrument has very strong antibacterial, antiinflammatory, dry temperature, removing the necrotic tissue, granulation promoting etc.; Also have very strong pain relieving, antipruritic effect; All patients eliminate rapidly the sufferings sensation behind coating, pus and blood after 24 hours, rot, the diabrosis phenomenon begins to change the new again raw meat of beginning; No matter be that the state of an illness is light and heavy, all patients through the treatment of this medicine all cured in 7 days at the latest.

Claims (4)

1. treat beriberic medicine for external use for one kind; Its active ingredient is made up of the crude drug of following weight percentage: Rhizoma Smilacis Glabrae 15-35%, Radix Stephaniae Tetrandrae 15-35%, Radix seu Caulis Derridis Trifoliatae 10-25%, Galla Chinensis 10-20%, Borax 7-15%; Wherein the dosage form of medicine for external use is a unguentum; Said unguentum forms with the solvent composition modulation, and said solvent composition is that the HUOXIANG ZHENGQI SHUI medicament is or/and ethanol.
2. the beriberic medicine for external use of treatment according to claim 1, wherein Rhizoma Smilacis Glabrae 20-30%, Radix Stephaniae Tetrandrae 20-30%, derris dust 15-25%, Galla Chinensis 15-20%, Borax 10-12%.
3. the beriberic medicine for external use of treatment according to claim 2, wherein Rhizoma Smilacis Glabrae 30%, Radix Stephaniae Tetrandrae 20%, derris dust 20%, Galla Chinensis 18%, Borax 12%.
4. the method for preparing of the beriberic medicine for external use of the arbitrary described treatment of claim 1-3, each component of percentage composition weighting raw materials is ground into smalls by weight, and mixing adds solvent composition, stirs the furnishing paste and gets final product.
CN201110141184XA 2011-05-30 2011-05-30 External applied medicine for treating beriberi and preparation method thereof Expired - Fee Related CN102210825B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110141184XA CN102210825B (en) 2011-05-30 2011-05-30 External applied medicine for treating beriberi and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110141184XA CN102210825B (en) 2011-05-30 2011-05-30 External applied medicine for treating beriberi and preparation method thereof

Publications (2)

Publication Number Publication Date
CN102210825A CN102210825A (en) 2011-10-12
CN102210825B true CN102210825B (en) 2012-11-14

Family

ID=44742509

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110141184XA Expired - Fee Related CN102210825B (en) 2011-05-30 2011-05-30 External applied medicine for treating beriberi and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102210825B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103961557A (en) * 2014-04-29 2014-08-06 广西健宝石斛有限责任公司 Externally-used traditional Chinese medicine containing dendrobium officinale and used for treating beriberi

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
戴秀娟.足癣复发 试试验方.《中国中医药报》.2007,004. *

Also Published As

Publication number Publication date
CN102210825A (en) 2011-10-12

Similar Documents

Publication Publication Date Title
CN104258319A (en) Traditional Chinese medicinal spray for treating bovine foot rot
CN104013878A (en) Foot-bathing medicinal vinegar for quickly treating dermatophytosis and preparation method thereof
CN103100075B (en) Medicament for treating eczema
CN108578465A (en) A kind of Chinese medicine composition and its preparation method and application
CN102210825B (en) External applied medicine for treating beriberi and preparation method thereof
CN105749088A (en) Traditional Chinese medicine composition for treating mange and acariasis of fur animals and preparation method and application thereof
CN1108810C (en) Medicine for treating psoriasis and preparing process thereof
CN114081938B (en) Bee therapy patch and preparation method thereof
CN105213584A (en) A kind of Chinese medicine composition for the treatment of eczema and preparation method thereof
CN105343245A (en) Chinese medical spray for treating furunculosis, sore and furuncle and hemorrhoid
Vodoslavskyi The quantitative content of the phenolic compounds in the Stellaria media herb
CN101474261B (en) Chinese medicine for treating rheumatic osteonosus
CN110237140A (en) A kind of Eradicates necrotic tissue and promoting muscle growing Chinese medicine composition and preparation method thereof
CN101352521B (en) Onychomycosis medicine and preparation method thereof
CN101375924A (en) Externally appiled Chinese medicinal composition for treating chronic psoriasis in resting stage
CN104069410A (en) Liquid medicine for treating dermatophytosis
CN104055720A (en) Itch-relieving and skin-caring lotion
CN1176708C (en) Capsule for treating psora
CN1141117C (en) Aloe wine for treating injury
CN108420980A (en) It is a kind of treat skin injury, bacterium infection antibacterial ointment and preparation method thereof
CN1143683C (en) Exterior-applied black plaster for treating bone diseases and its preparing process
CN102670815B (en) External traditional Chinese medicine for curing beriberi
CN107029158A (en) A kind of compound Chinese herb external preparation for treating a rabbits mange
CN1288751A (en) Psoriasis treating composition
CN105983035A (en) Traditional Chinese medicine powder spray for treating ulcer wound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Free format text: FORMER OWNER: AN JINLONG

Effective date: 20120831

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Wang Youfu

Inventor before: Wang Youfu

Inventor before: An Jinlong

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: WANG YOUFU AN JINLONG TO: WANG YOUFU

TA01 Transfer of patent application right

Effective date of registration: 20120831

Address after: 010070 box 2001, the Inner Mongolia Autonomous Region, Hohhot

Applicant after: Wang Youfu

Address before: 010070 box 2001, the Inner Mongolia Autonomous Region, Hohhot

Applicant before: Wang Youfu

Applicant before: An Jinlong

C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121114

Termination date: 20140530